Synthesis and Applications of Nanoparticles in Biosensing Systems
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Caspase-1 Biosensor to Monitor the Progression of Inflammation in Vivo
Published October 2, 2019, doi:10.4049/jimmunol.1900619 The Journal of Immunology A Caspase-1 Biosensor to Monitor the Progression of Inflammation In Vivo Sarah Talley,* Olga Kalinina,† Michael Winek,‡ Wonbeom Paik,† Abigail R. Cannon,* Francis Alonzo, III,† Mashkoor A. Choudhry,* Katherine L. Knight,† and Edward M. Campbell*,†,‡ Inflammasomes are multiprotein complexes that coordinate cellular inflammatory responses and mediate host defense. Following recognition of pathogens and danger signals, inflammasomes assemble and recruit and activate caspase-1, the cysteine protease that cleaves numerous downstream targets, including pro–IL-1b and pro–IL-18 into their biologically active form. In this study, we sought to develop a biosensor that would allow us to monitor the initiation, progression, and resolution of inflammation in living animals. To this end, we inserted a known caspase-1 target sequence into a circularly permuted luciferase construct that becomes bioluminescent upon protease cleavage. This biosensor was activated in response to various inflammatory stimuli in human monocytic cell lines and murine bone marrow–derived macrophages. Next, we generated C57BL/6 transgenic mice constitutively expressing the caspase-1 biosensor. We were able to monitor the spatiotemporal dynamics of caspase-1 activation and onset of inflammation in individual animals in the context of a systemic bacterial infection, colitis, and acute graft-versus-host disease. These data established a model whereby the development and progression of inflammatory responses can be monitored in the context of these and other mouse models of disease. The Journal of Immunology, 2019, 203: 000–000. umerous cell types, canonically cells of the innate im- filamentous complexes, providing a platform for the recruitment mune system, express cytosolic, nuclear, and membrane- and subsequent activation of caspase-1 (1–4, 8, 10–15). -
Raman Spectroscopic Characterization and Analysis of Agricultural and Biological Systems Qi Wang Iowa State University
Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2013 Raman spectroscopic characterization and analysis of agricultural and biological systems Qi Wang Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Agriculture Commons, Biomedical Commons, Bioresource and Agricultural Engineering Commons, and the Biostatistics Commons Recommended Citation Wang, Qi, "Raman spectroscopic characterization and analysis of agricultural and biological systems" (2013). Graduate Theses and Dissertations. 13019. https://lib.dr.iastate.edu/etd/13019 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Raman spectroscopic characterization and analysis of agricultural and biological systems by Qi Wang A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Agricultural Engineering Program of Study Committee: Chenxu Yu, Major Professor Jacek Adam Koziel Kenneth J Koehler Lie Tang Sinisa Grozdanic Iowa State University Ames, Iowa 2013 Copyright © Qi Wang, 2013. All rights reserved. ii TABLE OF CONTENTS LIST OF FIGURES………………………………………………………………………………...…..v LIST OF TABLES.................................................................................................................................vi -
The Future for Biosensors in Biopharmaceutical Production
Pharmaceutical Commentary BRACEWELL & POLIZZI The future for biosensors in biopharmaceutical production 2 Commentary The future for biosensors in biopharmaceutical production Pharm. Bioprocess. Keywords: bioprocess monitoring • bioprocess control • in-vivo biosensor • PAT Daniel G Bracewell*,1 • synthetic biology & Karen M Polizzi2 1The Advanced Centre for Biochemical Engineering, Department of Biochemical A defining feature of bioprocesses is the need straightforward. This is not to say there have Engineering, University College London, for measurement, monitoring and control; in not been significant successes: Torrington Place, London, WC1E 7JE, UK the context of biopharmaceuticals this need 2Department of Life Sciences & Centre • The world’s diabetic population depends is further heightened by the absolute require- for Synthetic Biology & Innovation, on blood glucose measurements to admin- Imperial College London, London, UK ment to ensure the quality of the product [1] . ister insulin based on an amperometric *Author for correspondence: This is evidenced by the size of bioanalytical based biosensor technology (enzyme elec- [email protected] endeavor found within the R&D programs trodes). This represents the largest single of the major biopharmaceutical companies biosensor application in terms of numbers and the supplier industry that caters for this of devices and market size; instrumentation need. It is a need that grows at a pace reflected in the initiatives involv- • Optical biosensors, largely surface plas- ing the regulatory authorities such as PAT mon resonance (BIAcore) has become central to the larger vision of QbD. At the the default method to directly mea- core of these attempts to improve biophar- sure protein–protein interactions in the maceutical production is the need for rapid, laboratory. -
Biosensors and Bioelectronics 141 (2019) 111467
Biosensors and Bioelectronics 141 (2019) 111467 Contents lists available at ScienceDirect Biosensors and Bioelectronics journal homepage: www.elsevier.com/locate/bios Designing and fabrication of new VIP biosensor for the rapid and selective detection of foot-and-mouth disease virus (FMDV) T ∗∗ Heba A. Husseina,c,1, Rabeay Y.A. Hassana,b,1, Rasha Mohamed El Nashard, , Samy A. Khalile, ∗ Sayed A. Salemc, Ibrahim M. El-Sherbinya, a Nanomaterials Laboratory, Center for Materials Science, Zewail City of Science and Technology, 6th October City, 12578, Giza, Egypt b Applied Organic Chemistry Department, National Research Centre (NRC), Dokki, 12622, Giza, Egypt c Virology Department, Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Egypt d Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt e Microbiology Department, Faculty of Veterinary Medicine, Alexandria University, Egypt ARTICLE INFO ABSTRACT Keywords: Foot and mouth disease virus (FMDV), is a highly contagious virus due to its ease of transmission. FMDV has Foot and mouth disease virus (FMDV) seven genetically distinguished serotypes with many subtypes within each serotype. The traditional diagnostic Virus imprinted polymers (VIPs) methods of FMDV have demonstrated many drawbacks related to sensitivity, specificity, and cross-reactivity. In Screen printed electrode (SPE) the current study, a new viral imprinted polymer (VIP)-based biosensor was designed and fabricated for the Biomimetic virus biosensors rapid and selective detection of the FMDV. The bio-recognition components were formed via electrochemical polymerization of the oxidized O-aminophenol (O-AP) film imprinted with FMDV serotype O on a gold screen- printed electrode (SPE). The overall changes in the design template have been investigated using cyclic vol- tammetry (CV), atomic force microscopy (AFM), Field emission-scanning electron microscopy (FE-SEM), and Fourier-transform infrared spectroscopy (FT-IR). -
Novel Microwire-Based Biosensor Probe for Simultaneous Real-Time Measurement of Glutamate and GABA Dynamics in Vitro and in Vivo
www.nature.com/scientificreports OPEN Novel microwire‑based biosensor probe for simultaneous real‑time measurement of glutamate and GABA dynamics in vitro and in vivo P. Timothy Doughty1,4, Imran Hossain2,4, Chenggong Gong2, Kayla A. Ponder1, Sandipan Pati3, Prabhu U. Arumugam1,2* & Teresa A. Murray1* Glutamate (GLU) and γ-aminobutyric acid (GABA) are the major excitatory (E) and inhibitory (I) neurotransmitters in the brain, respectively. Dysregulation of the E/I ratio is associated with numerous neurological disorders. Enzyme‑based microelectrode array biosensors present the potential for improved biocompatibility, localized sample volumes, and much faster sampling rates over existing measurement methods. However, enzymes degrade over time. To overcome the time limitation of permanently implanted microbiosensors, we created a microwire-based biosensor that can be periodically inserted into a permanently implanted cannula. Biosensor coatings were based on our previously developed GLU and reagent-free GABA shank-type biosensor. In addition, the microwire biosensors were in the same geometric plane for the improved acquisition of signals in planar tissue including rodent brain slices, cultured cells, and brain regions with laminar structure. We measured real-time dynamics of GLU and GABA in rat hippocampal slices and observed a signifcant, nonlinear shift in the E/I ratio from excitatory to inhibitory dominance as electrical stimulation frequency increased from 10 to 140 Hz, suggesting that GABA release is a component of a homeostatic mechanism in the hippocampus to prevent excitotoxic damage. Additionally, we recorded from a freely moving rat over fourteen weeks, inserting fresh biosensors each time, thus demonstrating that the microwire biosensor overcomes the time limitation of permanently implanted biosensors and that the biosensors detect relevant changes in GLU and GABA levels that are consistent with various behaviors. -
Analytical Chemistry in the 21St Century: Challenges, Solutions, and Future Perspectives of Complex Matrices Quantitative Analyses in Biological/Clinical Field
Review Analytical Chemistry in the 21st Century: Challenges, Solutions, and Future Perspectives of Complex Matrices Quantitative Analyses in Biological/Clinical Field 1, 2, 2, 3 Giuseppe Maria Merone y, Angela Tartaglia y, Marcello Locatelli * , Cristian D’Ovidio , Enrica Rosato 3, Ugo de Grazia 4 , Francesco Santavenere 5, Sandra Rossi 5 and Fabio Savini 5 1 Department of Neuroscience, Imaging and Clinical Sciences, University of Chieti–Pescara “G. d’Annunzio”, Via dei Vestini 31, 66100 Chieti, Italy; [email protected] 2 Department of Pharmacy, University of Chieti-Pescara “G. d’Annunzio”, Via Dei Vestini 31, 66100 Chieti (CH), Italy; [email protected] 3 Section of Legal Medicine, Department of Medicine and Aging Sciences, University of Chieti–Pescara “G. d’Annunzio”, 66100 Chieti, Italy; [email protected] (C.D.); [email protected] (E.R.) 4 Laboratory of Neurological Biochemistry and Neuropharmacology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milano, Italy; [email protected] 5 Pharmatoxicology Laboratory—Hospital “Santo Spirito”, Via Fonte Romana 8, 65124 Pescara, Italy; [email protected] (F.S.); [email protected] (S.R.); [email protected] (F.S.) * Correspondence: [email protected]; Tel.: +39-0871-3554590; Fax: +39-0871-3554911 These authors contributed equally to the work. y Received: 16 September 2020; Accepted: 16 October 2020; Published: 30 October 2020 Abstract: Nowadays, the challenges in analytical chemistry, and mostly in quantitative analysis, include the development and validation of new materials, strategies and procedures to meet the growing need for rapid, sensitive, selective and green methods. -
Space Biology Research and Biosensor Technologies: Past, Present, and Future †
biosensors Perspective Space Biology Research and Biosensor Technologies: Past, Present, and Future † Ada Kanapskyte 1,2, Elizabeth M. Hawkins 1,3,4, Lauren C. Liddell 5,6, Shilpa R. Bhardwaj 5,7, Diana Gentry 5 and Sergio R. Santa Maria 5,8,* 1 Space Life Sciences Training Program, NASA Ames Research Center, Moffett Field, CA 94035, USA; [email protected] (A.K.); [email protected] (E.M.H.) 2 Biomedical Engineering Department, The Ohio State University, Columbus, OH 43210, USA 3 KBR Wyle, Moffett Field, CA 94035, USA 4 Mammoth Biosciences, Inc., South San Francisco, CA 94080, USA 5 NASA Ames Research Center, Moffett Field, CA 94035, USA; [email protected] (L.C.L.); [email protected] (S.R.B.); [email protected] (D.G.) 6 Logyx, LLC, Mountain View, CA 94043, USA 7 The Bionetics Corporation, Yorktown, VA 23693, USA 8 COSMIAC Research Institute, University of New Mexico, Albuquerque, NM 87131, USA * Correspondence: [email protected]; Tel.: +1-650-604-1411 † Presented at the 1st International Electronic Conference on Biosensors, 2–17 November 2020; Available online: https://iecb2020.sciforum.net/. Abstract: In light of future missions beyond low Earth orbit (LEO) and the potential establishment of bases on the Moon and Mars, the effects of the deep space environment on biology need to be examined in order to develop protective countermeasures. Although many biological experiments have been performed in space since the 1960s, most have occurred in LEO and for only short periods of time. These LEO missions have studied many biological phenomena in a variety of model organisms, and have utilized a broad range of technologies. -
Current Biosensor Technologies in Drug Discovery
Biosensor 5/7/06 12:37 Page 68 Assays Current biosensor technologies in drug discovery By Dr Matthew A. Over the past two decades the benefits of biosensor analysis have begun to Cooper make an impact in the market, and systems are beginning to be used as mainstream research tools in many laboratories1,2. Biosensors are devices that use biological or chemical receptors to detect analytes in a sample.They give detailed information on the binding affinity, and in many cases also the binding kinetics of an interaction.Typically, the receptor molecule must be connected in some way to a transducer that produces an electrical signal in real-time. Label- free biosensors do not require the use of reporter elements (fluorescent, luminescent, radiometric, or colorimetric) to facilitate measurements. Detailed information on an interaction can be obtained during analysis while minimising sample processing requirements and assay run times3. Unlike label- and reporter-based technologies that simply confirm the presence of the detector molecule, label-free techniques can provide direct information on analyte binding to target molecules typically in the form of mass addition or depletion from the surface of the sensor substrate, or measuring changes in the heat capacity of a sample4. However, these technologies have failed to gain widespread acceptance due to technical constraints, low throughput, high user expertise requirements, and cost.While they can be powerful tools in the hands of a skilled user evaluating purified samples, they are not readily adapted to every day lab use where simple to understand results on high numbers of samples are the norm.This article seeks to address some of the issues surrounding the un-met needs in the market place, and the difficulties faced by technology developers in meeting these needs with innovative products. -
Surface-Enhanced Raman Spectroscopy for Bioanalysis and Diagnosis
Showcasing the Surface-enhanced Raman Spectroscopy (SERS) technique for Bioanalysis and Diagnosis As featured in: applications by a group of researchers led by Prof Liwu Volume 13 Number 27 21 July 2021 Zhang from Fudan University and Prof Ventsislav Valev Pages 11581-12046 from the University of Bath. Nanoscale rsc.li/nanoscale Surface-enhanced Raman spectroscopy for bioanalysis and diagnosis SERS is an eff ective analytical technique that has excellent potential in bioanalysis and diagnosis as demonstrated by its increasing applications in vivo . SERS fi nds a broad range of applications with clinical relevance, such as biological ISSN 2040-3372 PAPER Shifeng Zhao et al. The sign reversal of anomalous Hall eff ect derived from the transformation of scattering eff ect in cluster-assembled sensing, drug delivery, single cell assays, early stage cancer Ni 0.8 Fe 0.2 nanostructural fi lms screening and fast detection of pathogens. We present a comprehensive survey of SERS-based assays, from basic See Nicoleta E. Dina , Ventsislav K. considerations to bioanalytical applications. Valev, Liwu Zhang et al. , Nanoscale , 2021, 13 , 11593. rsc.li/nanoscale Registered charity number: 207890 Nanoscale View Article Online REVIEW View Journal | View Issue Surface-enhanced Raman spectroscopy for bioanalysis and diagnosis Cite this: Nanoscale, 2021, 13, 11593 Muhammad Ali Tahir,†a Nicoleta E. Dina, *†b Hanyun Cheng,a Ventsislav K. Valev *c and Liwu Zhang *a,d In recent years, bioanalytical surface-enhanced Raman spectroscopy (SERS) has blossomed into a fast- growing research area. Owing to its high sensitivity and outstanding multiplexing ability, SERS is an effective analytical technique that has excellent potential in bioanalysis and diagnosis, as demonstrated by its increasing applications in vivo. -
The Application of Whole Cell-Based Biosensors for Use in Environmental Analysis and in Medical Diagnostics
sensors Review The Application of Whole Cell-Based Biosensors for Use in Environmental Analysis and in Medical Diagnostics Qingyuan Gui 1, Tom Lawson 2, Suyan Shan 1, Lu Yan 1 and Yong Liu 1,* 1 Laboratory of Nanoscale Biosensing and Bioimaging, Instiute of Advanced Materials for Nano-Bio Applications, School of Ophthalmology and Optometry, Wenzhou Medical University, 270 Xueyuanxi Road, Wenzhou 325027, China; [email protected] (Q.G.); [email protected] (S.S.); [email protected] (L.Y.) 2 ARC Center of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW 2109, Australia; [email protected] * Correspondence: [email protected]; Tel.: +86-577-8806-7973 Received: 11 May 2017; Accepted: 8 July 2017; Published: 13 July 2017 Abstract: Various whole cell-based biosensors have been reported in the literature for the last 20 years and these reports have shown great potential for their use in the areas of pollution detection in environmental and in biomedical diagnostics. Unlike other reviews of this growing field, this mini-review argues that: (1) the selection of reporter genes and their regulatory proteins are directly linked to the performance of celllular biosensors; (2) broad enhancements in microelectronics and information technologies have also led to improvements in the performance of these sensors; (3) their future potential is most apparent in their use in the areas of medical diagnostics and in environmental monitoring; and (4) currently the most promising work is focused on the better integration of cellular sensors with nano and micro scaled integrated chips. With better integration it may become practical to see these cells used as (5) real-time portable devices for diagnostics at the bedside and for remote environmental toxin detection and this in situ application will make the technology commonplace and thus as unremarkable as other ubiquitous technologies. -
Two-Dimensional Nanostructures for Electrochemical Biosensor
sensors Review Two-Dimensional Nanostructures for Electrochemical Biosensor Reem Khan 1 , Antonio Radoi 2 , Sidra Rashid 3, Akhtar Hayat 3 , Alina Vasilescu 4 and Silvana Andreescu 1,* 1 Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, NY 13699, USA; [email protected] 2 National Institute for Research and Development in Microtechnology—IMT Bucharest, 126A Erou Iancu Nicolae Street, 077190 Voluntari, Romania; [email protected] 3 IRCBM, COMSATS University Islamabad, Lahore Campus, Lahore 54000, Pakistan; [email protected] (S.R.); [email protected] (A.H.) 4 International Centre of Biodynamics, 1B Intrarea Portocalelor, 060101 Bucharest, Romania; [email protected] * Correspondence: [email protected] Abstract: Current advancements in the development of functional nanomaterials and precisely designed nanostructures have created new opportunities for the fabrication of practical biosensors for field analysis. Two-dimensional (2D) and three-dimensional (3D) nanomaterials provide unique hierarchical structures, high surface area, and layered configurations with multiple length scales and porosity, and the possibility to create functionalities for targeted recognition at their surface. Such hierarchical structures offer prospects to tune the characteristics of materials—e.g., the electronic properties, performance, and mechanical flexibility—and they provide additional functions such as structural color, organized morphological features, and the ability to recognize and respond to external stimuli. Combining these unique features of the different types of nanostructures and using them as support for bimolecular assemblies can provide biosensing platforms with targeted Citation: Khan, R.; Radoi, A.; Rashid, S.; Hayat, A.; Vasilescu, A.; recognition and transduction properties, and increased robustness, sensitivity, and selectivity for Andreescu, S. Two-Dimensional detection of a variety of analytes that can positively impact many fields. -
The Bio Revolution: Innovations Transforming and Our Societies, Economies, Lives
The Bio Revolution: Innovations transforming economies, societies, and our lives economies, societies, our and transforming Innovations Revolution: Bio The The Bio Revolution Innovations transforming economies, societies, and our lives May 2020 McKinsey Global Institute Since its founding in 1990, the McKinsey Global Institute (MGI) has sought to develop a deeper understanding of the evolving global economy. As the business and economics research arm of McKinsey & Company, MGI aims to help leaders in the commercial, public, and social sectors understand trends and forces shaping the global economy. MGI research combines the disciplines of economics and management, employing the analytical tools of economics with the insights of business leaders. Our “micro-to-macro” methodology examines microeconomic industry trends to better understand the broad macroeconomic forces affecting business strategy and public policy. MGI’s in-depth reports have covered more than 20 countries and 30 industries. Current research focuses on six themes: productivity and growth, natural resources, labor markets, the evolution of global financial markets, the economic impact of technology and innovation, and urbanization. Recent reports have assessed the digital economy, the impact of AI and automation on employment, physical climate risk, income inequal ity, the productivity puzzle, the economic benefits of tackling gender inequality, a new era of global competition, Chinese innovation, and digital and financial globalization. MGI is led by three McKinsey & Company senior partners: co-chairs James Manyika and Sven Smit, and director Jonathan Woetzel. Michael Chui, Susan Lund, Anu Madgavkar, Jan Mischke, Sree Ramaswamy, Jaana Remes, Jeongmin Seong, and Tilman Tacke are MGI partners, and Mekala Krishnan is an MGI senior fellow.